Sofinnova Ventures »

Illumina shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Illumina (ILMN) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Illumina

Tip: Access up to 7 years of quarterly data

All positions including Illumina held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Illumina by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.3M 41k 130.41

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Gilead Sciences (GILD)
Abbvie (ABBV)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics Call Option (AXSM)
Arrivent Biopharma (AVBP)
AstraZeneca Sponsored Adr (AZN)
Stryker Corporation (SYK)
Replimune Group (REPL)
Incyte Corporation (INCY)
Rapport Therapeutics (RAPP)
Soleno Therapeutics (SLNO)
Boston Scientific Corporation (BSX)

View all positions for Sofinnova Ventures

Top funds holding Illumina

BlackRock
Capital World Investors
Vanguard Group
State Street Corporation
Loomis, Sayles and
WCM Investment Management
Bank of New York Mellon
Baillie Gifford & Co
Geode Capital Management
PRIMECAP Management Company
Guardcap Asset Management
Henderson Group
Brown Advisory Holdings Incorporated
PointState Capital
Norges Bank Investment Management

View all funds holding Illumina